Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07734038) titled 'Venetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma' on July 24.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Kerry Rogers
Condition:
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Intervention:
Procedure: Biospecimen Collection
Procedure: Bone Marrow Aspiration
Procedure: Bone Marrow Biopsy
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging
Drug: Venetoclax
Recruitment Status: Not recruiting...